1975 Ford Ltd on 2040-cars

Auto blog

2021 Ford Escape PHEV finally reaches dealers

Last October – which feels like both five minutes and five years ago – Ford had to push the Escape PHEV sales date back to this year. The holdup arose because Ford had to recall the Escape's European twin, the Kuga PHEV, over a fire risk thought to center on the high-voltage battery. At the time, a Ford spokesperson said, "We are moving full scale production of Escape PHEV to the 2021 model year. The first Escape PHEVs will be sold next year." With just three months left in 2021, a Ford spokesperson confirmed to Ford Authority that the Escape PHEV has finally made it to dealer lots. The end of the Escape PHEV's long and winding road comes about a week after the Lincoln Corsair Grand Touring reached dealers. The compact luxury plug-in hybrid debuted at the 2019 LA Auto Show and was intended to go on sale in the summer of last year. But because it uses the same powertain as in the Escape, Ford had to delay the Lincoln as well.  Now that you can finally buy them, here's the quick recap. Both start with a naturally aspirated 2.5-liter inline-4 and an electric motor powering the front wheels, and a 14.4-kWh battery providing juice. The Escape makes 200 horsepower, can go 37 miles on all-electric driving, is EPA-rated at 105 miles per gallon equivalent (MPGe), and returns a combined 40 mpg if the battery's dead. It starts at $34,320 before incentives. The Lincoln adds an electric motor with a single-speed transmission to power the rear wheels, as Toyota has done with the all-wheel-drive Prius, RAV4 Hybrid and Lexus UX250h. Output in the Lincoln is 266 ponies, it manages 28 miles on pure electric driving, is EPA rated at 78 MPGe, and returns a combined 33 mpg on gasoline alone. It starts at $51,485 before incentives. Related Video: This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings.

Our love of SUVs is killing people in the streets

Americans are fond of supersized fast-food meals and colossal convenience-store fountain drinks, even though they're clearly bad for our health and U.S. adults keep getting fatter. We also like large vehicles, and our love affair with SUVs is killing people in the streets. According to a recent investigation by the Detroit Free Press/USA Today, the increase in SUV sales over the past several years coincides with a sharp rise in pedestrian deaths in the U.S. — up 46 percent since 2009, with nearly 6,000 people killed in 2016 alone. With SUV sales surpassing sedans in 2014 and pickups and SUVs currently accounting for 60 percent of new vehicle sales, it's no wonder Ford announced in April plans to cease U.S. sales of almost all passenger cars. And this followed Fiat Chrysler's move to virtually an all-truck, -SUV and -crossover lineup. While the Freep/USA Today investigation found that the simultaneous surge in SUV sales and pedestrian deaths comes down to vehicle size, it also points to a lack of action on the part of the National Highway Traffic Safety Administration (NHTSA), even though it knew of the dangers SUVs pose to pedestrians. Also blamed are automakers dragging their feet on implementing active safety features. Using federal accident data, the Insurance Institute for Highway Safety (IIHS) determined that there was an 81 percent increase in single-vehicle pedestrian fatalities involving SUVs between 2009 and 2016. Freep/USA Today's analysis of the same data by counting vehicles that struck and killed pedestrians instead of the number of people killed showed a 69 percent increase in SUV involvement. As far back as 2001, researchers at Rowan University forecasted a rise in pedestrian deaths as Americans began switching to SUVs. "In the United States, passenger vehicles are shifting from a fleet populated primarily by cars to a fleet dominated by light trucks and vans," the researchers wrote, with light trucks comprising SUVs.

Britain orders 10,000 ventilators from F1/McLaren/Mercedes/Ford/Rolls-Royce/Airbus

Paramedics and ambulance personnel get instructions from a command unit outside London's ExCel Centre arena, which is being turned into a 4,000 bed temporary hospital called NHS Nightingale to deal with coronavirus patients. The hospital is due to open Monday, March 30. / AP     LONDON — Britain has ordered 10,000 ventilators from a consortium of leading aerospace, engineering and Formula One racing companies which will start production this week in response to an urgent government call for industry to help save lives. The 27-strong team, including Airbus, BAE Systems, Ford and Rolls-Royce, have joined forces to ramp up production of a ventilator made by Smiths Group, which supports those with complications from COVID-19. The consortium, which also includes seven Formula One teams including McLaren and Mercedes, home to World Champion Lewis Hamilton, said they had pulled staff off existing projects to meet the national need. Some 1,228 people have died from coronavirus in the United Kingdom and a senior health official said on Saturday the country would be doing well if it manages to keep the death toll below 20,000. "This consortium brings together some of the most innovative companies in the world," Dick Elsy, the head of the consortium, said in a statement. "I am confident this consortium has the skills and tools to make a difference and save lives." The United Kingdom, which initially only had 5,000 ventilators available in its National Health Service, has been trying to secure additional supplies after realising it needed 30,000 to cope with the peak of the outbreak. Prime Minister Boris Johnson, who is now in isolation in Downing Street after testing positive for coronavirus, made an emergency appeal earlier this month for manufacturers to retool their production lines and start making specialist health equipment including ventilators. Britain now has about 8,000 ventilators, with another 8,000 on order from international manufacturers that are due in coming weeks. Last week it placed an order for a newly-designed model from the vacuum cleaner company Dyson that will need to be approved by the health regulator. Mercedes part of a separate effort, too Separately on Monday a second consortium including Mercedes Formula One and other F1 teams said it had developed in less than a week a new version of a breathing aid that can help coronavirus patients.